Harris Associates’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,245
Closed -$557K 141
2023
Q2
$557K Sell
1,245
-661
-35% -$333K ﹤0.01% 131
2023
Q1
$925K Sell
1,906
-43,902
-96% -$21.7M ﹤0.01% 129
2022
Q4
$23.5M Sell
45,808
-29,565
-39% -$15.5M 0.05% 102
2022
Q3
$36.6M Sell
75,373
-882,050
-92% -$429M 0.06% 100
2022
Q2
$448M Sell
957,423
-2,108,511
-69% -$938M 0.71% 38
2022
Q1
$1.33B Sell
3,065,934
-1,373,346
-31% -$574M 1.76% 13
2021
Q4
$2.06B Buy
4,439,280
+44,164
+1% +$19.5M 3.21% 5
2021
Q3
$1.71B Buy
4,395,116
+1,032,244
+31% +$438M 2.72% 9
2021
Q2
$1.49B Buy
3,362,872
+299,345
+10% +$131M 2.37% 9
2021
Q1
$1.28B Buy
3,063,527
+2,124,735
+226% +$848M 2.2% 13
2020
Q4
$385M Buy
938,792
+93,637
+11% +$38.9M 0.74% 43
2020
Q3
$350M Sell
845,155
-8,855
-1% -$3.56M 0.85% 39
2020
Q2
$331M Sell
854,010
-57,829
-6% -$21.6M 0.81% 39
2020
Q1
$286M Buy
911,839
+17,543
+2% +$5.92M 0.79% 38
2019
Q4
$328M Buy
894,296
+57,711
+7% +$18.3M 0.58% 48
2019
Q3
$214M Buy
+836,585
New +$235M 0.42% 66

Other funds holding HUM

Harris Associates's HUM Position: Q3 2023 in Review

Harris Associates sold out of Humana (HUM) in Q3 2023, closing a stake of 1,245 shares — an estimated $557K sold.

Harris Associates first reported a position in HUM in Q3 2019 and held it in 16 quarters. The position peaked at $2.06B in Q4 2021. 1,086 funds tracked by Wall St. Rank hold HUM as of Q3 2023.

  • Harris Associates reported no remaining Humana position as of Q3 2023 after selling out during the quarter.
  • Harris Associates sold 1,245 Humana shares in Q3 2023, an estimated $557K.
  • Harris Associates first reported a position in Humana in Q3 2019 and held it in 16 quarters.
  • Harris Associates's Humana position peaked at $2.06B in Q4 2021.
  • 1,086 funds tracked by Wall St. Rank held Humana as of Q3 2023.

Based on Harris Associates's 13F filing for Q3 2023, filed 14 Nov 2023.